ELV

NYSE · Health Care

Elevance Health Inc

Q: Who are Elevance Health Inc's main competitors?

UnitedHealth Group is the dominant force in U.S. managed care, competing with Elevance across commercial, Medicare Advantage, and Medicaid lines. Cigna and CVS Health (Aetna) compete heavily in employer-sponsored commercial insurance and pharmacy benefits. Centene and Molina Healthcare are more focused on government-sponsored Medicaid and marketplace plans, where they overlap with Elevance's government segment. For Medicare Advantage specifically, Humana is a major rival with a large and loyal senior membership base.

Q: How much does ELV stock cost right now?

ELV last closed at $378.07, up 1.38% in the most recent trading session. Over the past 52 weeks, the stock has traded between a low of $273.71 and a high of $424.24. The current price represents 69% of its 52-week range, which helps investors gauge where the stock sits relative to its recent trading history.

Q: What is the analyst consensus for ELV?

Among 28 analysts covering ELV, the consensus rating is Hold — 15 rate it a buy, 13 hold, and 0 sell. The average price target sits at $135.77, implying 64% downside from the current price. Keep in mind that analyst targets reflect 12-month expectations and can shift quickly after earnings reports or major company events.

Q: Does Elevance Health Inc make money?

Elevance Health Inc generated $190.81B in revenue during fiscal year 2026, with $5.43B reaching the bottom line as net income. The net profit margin of 2.8% reflects the competitive nature of its industry.

Q: Is ELV stock expensive based on earnings?

ELV trades at a P/E ratio of 15.52 on trailing earnings of $23.51 per share. That's roughly in line with the broader market average of ~20-25x. Comparing this multiple against Health Care sector peers gives better context than the broad market alone, since P/E norms vary significantly across industries.

S&P 500 Large-Cap Stocks Blue Chip Stocks Healthcare Stocks Best Dividend Stocks

$378.07

+5.15 (+1.38%)

As of May 9, 1:00 AM ET ·

Day Range $371.09 — $379.23

52W Range $273.71 — $424.24

Performance

1D —

1W —

1M —

3M +15.44%

6M +19.93%

1Y -9.27%

YTD +6.72%

Open$376.24

Previous Close$372.92

Day High$379.23

Day Low$371.09

52W High$424.24

52W Low$273.71

Volume—

Avg Volume1.60M

Market Cap81.37B

P/E Ratio15.52

EPS$23.51

SectorHealth Care

Technical Indicators

Full analysis →

SMA 50 $351.68 Above

SMA 200 $341.74 Above

RSI (14) 51 Neutral

Trend Golden Cross Bullish

Analyst Ratings

Hold

28 analysts

15 Buy 13 Hold 0 Sell

Price Target -64.1% upside

Current
$378.07

Target
$135.77

$112.32 $135.77 avg $190.73

Key Financials

	FY 2026	FY 2025	FY 2024
Revenue	190.81B	176.12B	28.12B
Net Income	5.43B	4.51B	3.74B
Profit Margin	2.8%	2.7%	13.3%
EBITDA	8.37B	7.34B	6.88B
Free Cash Flow	—	—	2.63B
Rev Growth	+8.3%	+8.3%	+22.0%
Debt/Equity	0.73	0.73	0.47

Dividend

Dividend Yield1.84%

Annual Dividend$6.82

Payout Ratio27.0%

Frequencyquarterly

Ex-Dividend—

Pay Date—

Recent Insider Activity

All Insiders →

Date	Insider	Type	Shares	Price	Value
Aug 21	DeVore Susan D.	Buy	3,502	$312.15	$1.09M
Jul 18	BOUDREAUX GAIL	Buy	144,854	$286.07	$41.44M
Jul 18	BOUDREAUX GAIL	Buy	149,970	$287.12	$43.06M
Jul 18	BOUDREAUX GAIL	Buy	151,020	$287.96	$43.49M
Apr 25	Kaye Mark	Sale	18,977	$424.82	$8.06M

About Elevance Health Inc

Elevance Health, Inc., formerly Anthem, is one of the largest health benefits companies in the United States, headquartered in Indianapolis, Indiana. The company provides health insurance and related services through affiliated health plans operating under the Blue Cross Blue Shield association and other brands. Elevance serves millions of members across commercial and specialty, government, and international markets through employer-sponsored plans, individual coverage, Medicare, and Medicaid programs. The company also operates Carelon, which provides pharmacy benefits management, behavioral health services, and care delivery solutions to improve health outcomes and affordability.

Health Care Peers

Symbol	Name	Price	Change	P/E	Mkt Cap
UNH	UnitedHealth Group Inc	$379.98	+2.77%	27.9	335.65B
ABT	Abbott Laboratories	$84.32	-3.09%	24.9	156.28B
ISRG	Intuitive Surgical Inc	$450.06	-0.76%	56.7	161.96B
SYK	Stryker Corp	$285.47	-2.98%	38.6	125.44B
MDT	Medtronic Plc	$76.15	-2.32%	23.2	106.97B
MCK	Mckesson Corp	$736.09	-2.47%	23.4	101.35B

ELV Frequently Asked Questions

What does Elevance Health Inc do?

Elevance Health is fundamentally in the business of managing healthcare costs and risk for millions of Americans. It collects premiums from employers, individuals, and government programs, then pays claims while keeping the spread — a model that rewards effective care management and network contracting. Its Carelon subsidiary adds a services layer, providing pharmacy benefits management and behavioral health services that help control medical costs. The company's Blue Cross Blue Shield licenses give it established, trusted brand recognition across most of its commercial markets.

Is ELV stock a good investment?

Elevance is one of the largest managed care companies in the U.S., with scale advantages in negotiating provider rates and managing risk pools. The stock has historically traded at a reasonable multiple relative to earnings growth, appealing to investors who want healthcare exposure with more predictability than hospital or biotech stocks. The central risk in recent years has been Medicaid margin pressure — as states adjust enrollment and reimbursement rates post-pandemic, medical cost ratios have become harder to forecast, creating earnings uncertainty that has weighed on the sector.

Who are Elevance Health Inc's main competitors?

UnitedHealth Group is the dominant force in U.S. managed care, competing with Elevance across commercial, Medicare Advantage, and Medicaid lines. Cigna and CVS Health (Aetna) compete heavily in employer-sponsored commercial insurance and pharmacy benefits. Centene and Molina Healthcare are more focused on government-sponsored Medicaid and marketplace plans, where they overlap with Elevance's government segment. For Medicare Advantage specifically, Humana is a major rival with a large and loyal senior membership base.

Does Elevance Health Inc pay dividends?

Elevance Health pays a regular quarterly dividend that has grown consistently over the years, reflecting the company's cash generation from its insurance operations. While the yield is modest relative to income-focused sectors, the company supplements dividends with share buybacks as the primary vehicle for returning capital. Managed care companies tend to be disciplined capital allocators, and Elevance's payout history reflects steady commitment to rewarding shareholders without overextending in a regulated industry.

How much does ELV stock cost right now?

ELV last closed at $378.07, up 1.38% in the most recent trading session. Over the past 52 weeks, the stock has traded between a low of $273.71 and a high of $424.24. The current price represents 69% of its 52-week range, which helps investors gauge where the stock sits relative to its recent trading history.

What is the analyst consensus for ELV?

Among 28 analysts covering ELV, the consensus rating is Hold — 15 rate it a buy, 13 hold, and 0 sell. The average price target sits at $135.77, implying 64% downside from the current price. Keep in mind that analyst targets reflect 12-month expectations and can shift quickly after earnings reports or major company events.

Does Elevance Health Inc make money?

Elevance Health Inc generated $190.81B in revenue during fiscal year 2026, with $5.43B reaching the bottom line as net income. The net profit margin of 2.8% reflects the competitive nature of its industry.

Is ELV stock expensive based on earnings?

ELV trades at a P/E ratio of 15.52 on trailing earnings of $23.51 per share. That's roughly in line with the broader market average of ~20-25x. Comparing this multiple against Health Care sector peers gives better context than the broad market alone, since P/E norms vary significantly across industries.

Is ELV stock going up or down?

Performance varies across timeframes, reflecting shifting market conditions. Returns by timeframe: +15.44% (3M), +19.93% (6M), -9.27% (1Y), +6.72% (YTD). Comparing these figures against the S&P 500 and sector benchmarks helps determine whether ELV is outperforming or lagging the broader market.